中国临床药学杂志

参考文献

[1]唐姝,陈志祥,陆伟根.重组人生长激素长效制剂的研究进展[J].世界临床药物,2014,35(1):36.

[2]包建华.重组人生长激素的应用研究进展[J].药学服务与研究,2008,8(4):272.

[3]杨欣,叶琳.人生长激素的应用和剂型研究[J].国际生物制品学杂志,2008,31(2):86.

[4]Baxter L,Bryant J,Cave CB,et al.Recombinant growth hormone for children and adolescents with Turner syndrome[J].Cochrane Database Syst Rev,2007,(1):CD003887.

[5]陈桂芬.重组人生长激素治疗矮小症的临床观察[J].中华全科医学,2013,11(10):1584.

[6]李卫,亓发芝,高金成.重组人生长激素对老化皮肤胶原蛋白代谢的作用[J].中国康复医疗,2006,10(37):78.

[7]赵东峰,李汉超,王悦然.基因工程人生长激素及其应用研究进展[J].广州化工,2010,38(2):44.

[8]秦薇,陈艳卿.重组人生长激素对大鼠心力衰竭的影响[J].国际心血管病杂志,2013,40(5):319.

[9]叶晓光,廖云珍,黄远明,等.生长激素治疗肝硬化低蛋白血症疗效与IGF-1、IGFBP-3变化关系[J].中国临床药学杂志,2001,102):80.

[10]邹紫红,郭毅斌,郑庆亦.重组人生长激素对严重烧伤后炎症反应的影响[A].中华医学会烧伤外科学分会2012年学术年会论文汇编.2012.

[11]Rosenfeld RG,Cohen P,Robison LL,et al.Long-term surveillance of growth hormone therapy[J].J Clin Endocrinol Metab,2012,97(1):168.

[12]燕芳龙,李洪森,王金龙,等.重组人生长激素稳定性研究进展[J].上海医药,2010,31(9):414.

[13]张芳,杨志强,王杏林.长效注射剂释药技术研究进展[J],中国新药杂志,2013,22(5):547.

[14]Cleland JL,Johnson OL,Putney S,el al.Recombinant huaman growth hormone poly(lactic-co-glycolic-acid)microsphere formulation development[J].Adv Drug Deliv Rev,1997,28(1):71.

[15]Yamagata YT,Misaki MF,Kurokawa T,et al.Preparation of a copoly(dllatic/glycolic acid)-zinc oxide complex and its utilization to microcapsules containing[J].Int J Pharm,2003,25(1):133.

[16]Takeda SY,Yamagata YT,Misaki MF,et al.Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique[J].J Control Release,2003,88(2):229.

[17]李唐棣,梅兴国,赵应征.重组人生长激素脂质体的制备及载药研究[J].中国生化药物杂志,2006,27(3):133.

[18]王晓玲,巩纯秀.重组人生长激素长效剂型的研究进展[J].中华儿科杂志,2010,48(4):317.

[19]Clark R,Olson K,MarianM,etal.Long-acting growth hormones produced by conjugation with polyethylene glycol[J].J Biol Chem,1996,271(36):21969.

[20]李湛军,杨化新,徐康森.聚乙二醇化重组人生长激素的长效作用及在体生物活性研究[J].中国临床药理学与治疗学,2005,10(11):1270.

[21]王荣海,魏练平,宋礼华,等.聚乙二醇修饰重组人生长激素的初步研究[J].生物学杂志,2004,21(2):20.

[22]郭凝,杨仲瑗,王俊玲.一种新型聚乙二醇化重组人生长激素的制备及性质考察[J].沈阳药科大学学报,2010,27(10):844.

[23]Reynolds RC.Metabolism and pharmacokinetics of sucrose acetate isobutyrate(SAIB)and sucrose octaisobutyrate(SOIB)in rats,dogs,monkeys or humans:a review[J].Food Chem Toxicol,1998,36(2):95.

[24]Reynolds RC,Chappel CI.Sucrose aceta isobutyrate(SAIB):historical aspects of its use in beverages and a review of toxicity studies prior to 1988[J].Food Chem Toxicol,1988,36(6):81.

[25]Okumu FW,Fielder LN,Dybdal PJ,et al.Sustained delivery of human growth hormone from a novel gel system:SABERTM[J].Biomaterials,2002,23(5):4353.

[26]Folkesson HG,Hedin L,Westr(o|¨)m BR.Lung to blood passage of human growth hormone after intratracheal instillation:stimulation of growth in hypophysectomized rats[J].J Endocrinol,1992,134(2):197.

[27]Patton JS,McCabe JG,Hansen SE,et al.Absorption of human growth hormone from the rat lung[J].Biotechnol Ther,1988,1(3):213.

[28]Bosquillon C,Preat V,Vanbever R.Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats[J].J Control Release,2004,96(2):233.

[29]Jalalipour M,Najafabadi AR,Gilani K,et al.Effect of dimethyl-betacyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats[J].J Pharm Sci,2008,97(12):5176.

[30]苗嘉恒,袁伟恩,金拓.重组人生长激素鼻腔给药系统研究进展[J].中国药房,2006,17(7):539.

[31]Baldwin PA,Klingbeil CK,Grimm CJ,et al.The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models[J].Pharm Res,1990,7(5):547.

[32]Agerhofm C,Bastholm L,Johansen PB,et al.Epithelial transport and bioavailability of intranasally administered human growth hormone formulated with the absorption enhancers didecanoyl-L-alpha-phosphatidylcholine and alpha-cyclodextrin in rabbit[J].J Pharm Sci,1994,83(12):1706.

[33]Bosquillon C,Preat V,Vanbever R.Pulmonary delivery of growth hormone using dry powers and visualization of its local fate in rats[J].J Control Release,2004,96(2):233.

[34]Azagury A,Khoury L,Enden G,et al.Ultrasound mediated transdermal drug delivery[J].Adv Drug Deliv Rev,2014,72:127.

[35]Park EJ,Werner J,Smith NB.Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer[J].Pharm Res,2007,24(7):1396.

[36]Krishnan G,Roberts MS,Grice J,et al.lontophoretic skin permeation of peptides:an investigation into the influence of molecular properties,iontophoretic conditions and formulation parameters[J].Drug Deliv Transl Res,2014,4(2):222.

[37]Patel H,Joshi A,Joshi A,et al.Effect of microporation on passive and iontophoretic delivery of diclofenac sodium[J J.Drug Dev Ind Pharm,2015,11:1.

[38]Sivamani RK,Liepmann D,Maibach HI.Microneedles and transdermal applications[J].Expert Opin Drug Deliv,2007,4(1):19.

[39]Wermeling DP,Banks SL,Hudson DA,et al.Microneedles permit transdermal delivery of a skin-impermeant medication to humans[J].Proc Natl Acad Sic,2008,105(6):2058.

[40]Williams AC,Barry BW.Penetration enhancer[J].Adv Drug Deliv Rev,2004,56(5):603.

[41]Karande P,Jain A,Mitragotri S.Discovery of transdermal penetration enhancers by high-throughput screening[J].Nat Biotechnol,2004.,22(2):192.

[42]Lee JW,Choi SO,Felner EI,et al.Dissolving microneedle patch for transdermal delivery of human growth hormone[J].Small,2011,7(7):531.

[43]Kumar V,Banga AK.Modulated iontophoretic delivery of small and large molecules through microchannels[J].Int J Pharm,2012,434(1-2):106.

[44]Bernard V,Andrasina T,Mornstein V,et al.Radiofrequency tissue ablation inside of metal stent-A thermographic study[J].IRBM,2014,35(3):164.

[45]Germani G,Pleguezuelo M,Gurusamy K,et al.Clinical outcomes of radiofrequency ablation,percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma:a meta-analysis[J].J Hepatol,2010,52(3):380.

[46]Sintov AC,Krymberk I,Daniel D,et al.Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs[J].J Control Release,2003,89(2):311.

[47]Levin G,Gershonowitz A,Sacks H,et al.Transdermal delivery of human growth hormone through RF-Microchannels[J].Pharm Res,2005,22(4):550.